Providence Health & Services
07/02/2026 | Press release | Archived content
Advancing cancer care through clinical trials
Advancing cancer care through clinical trials
July 2, 2026 Providence Oregon News Team
- Share this Article
Above: Dr. Natasha Edwin appears on KATU's "Family Matters."
July 2026
In 1970, the average cancer survival rate was 40%. Today, it's closer to 70%.
This progress is driven in large part by clinical trials - where research and patient care come together to advance treatment and improve outcomes.
Patients from throughout the Northwest and beyond travel to Portland to participate in these trials.
Natasha Edwin, M.D., a hematologist and medical oncologist at Providence Cancer Institute, recently shared how our trials made a difference for one woman from Walla Walla, Washington, on KATU's Family Matters.
Related news
See more of our services at Providence Cancer Institute of Oregon.
Read about a new clinical trial available to eligible patients with triple-negative breast cancer.
See a story about a patient's lifechanging story with support from a clinical trial.
Previous Article
Can Joy Improve Health Outcomes?
Research suggests that joy may play a larger role in health than many realize. Learn how cultivating positi...
Next Article
Celebrating a milestone: 100 heart transplants and counting
At Providence Heart Institute, a remarkable milestone reflects both innovation and compassion - 100 heart t...
Providence Health & Services published this content on July 02, 2026, and is solely responsible for the information contained herein. Distributed via Public Technologies (PUBT), unedited and unaltered, on August 17, 2026 at 16:26 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]